Related Experiment Videos
Correlation between cytogenetic data and ganglioside pattern in human meningiomas.
1Institute of General Physiology and Biological Chemistry, University of Milan, Italy.
International Journal of Cancer
|February 1, 1991
Summary
Loss of chromosome 22 in meningiomas correlates with altered ganglioside profiles. Tumors with chromosome 22 loss show higher GD3 ganglioside levels, suggesting a regulatory gene on chromosome 22.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Genetics
Background:
- Chromosome 22 alterations are linked to central nervous system tumors, especially meningiomas.
- Tumor development often involves changes in cell surface ganglioside patterns.
Purpose of the Study:
- To investigate the relationship between chromosome 22 status and ganglioside distribution in human meningiomas.
- To identify potential genes on chromosome 22 involved in ganglioside metabolism.
Main Methods:
- Cytogenetic analysis of 30 human meningiomas.
- Biochemical analysis of cell surface ganglioside content (GM3, GD3, GM1, GD1a, GD1b, GT).
- Correlation of cytogenetic data (monosomy 22) with ganglioside profiles.
Main Results:
- Meningiomas with partial or total monosomy 22 (13 tumors) showed significantly higher GD3 ganglioside content compared to tumors with normal chromosome 22 (17 tumors).
- Tumors without monosomy 22 predominantly featured GM3 ganglioside.
- Specific gangliosides (GM1, GD1a, GD1b, GT) varied in amount between the two groups.
Conclusions:
- A significant correlation exists between chromosome 22 status and the ratio of GM3 to GD3 gangliosides in meningiomas.
- Hypothesize a gene on chromosome 22 regulates enzymes involved in GD3 synthesis or degradation, impacting meningioma ganglioside profiles.